Bredt David sold RAPP
December 31, 2025 · Form 4 insider transaction
Bredt David sold 18,000 shares of Rapport Therapeutics, Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Disposed (sell-side)
Shares
18,000
Price
N/A
Total value
N/A
InsiderBredt David
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateDecember 31, 2025
Filing dateJanuary 5, 2026
Shares owned after410,642
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On December 4, 2024, the Reporting Person was granted performance-based restricted stock units ("PSUs") subject to the satisfaction of specified performance criteria as of December 31, 2025. The issuers Compensation Committee confirmed that the performance criteria had been met, resulting in the vesting of such PSUs effective December 31, 2025.